Company Update: Pfizer Inc (NYSE:PFE) – Corrected-Merck KGaA says avelumab alliance with Pfizer on track

[Reuters] – * Says avelumab alliance with Pfizer on track * Says it started investigating a novel, potential first-in- class bi-functional immunotherapy in clinical trials * Says working towards at least one additional . . . → Read More: Company Update: Pfizer Inc (NYSE:PFE) – Corrected-Merck KGaA says avelumab alliance with Pfizer on track Similar Articles: Company Update: Pfizer Inc (NYSE:PFE) – Gliknik Licensee Pfizer Receives Orphan Drug Designation From U.S. Food and Drug Administration for Drug Candidate Directed Towards Rare Neurological Disorder Company Update: Pfizer Inc (NYSE:PFE) – Pfizer wins EU approval for $15 bln Hospira buy Company Update: Pfizer Inc (NYSE:PFE) – Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D